NMD Pharma
NMD Pharma is a biotech company in Åbogade, Denmark, founded in 2015. It has raised $168.3M across 3 rounds, most recently an $81.3M Series B in November 2023.
- Headquarters
- Åbogade
- Employees
- 11–50
- Founded
- 2015
- Website
- nmdpharma.com
- Total Funding
- $168.3M
- Last Round
- $81.3M Series BNov 2023
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.
About
NMD Pharma is a clinical-stage biotechnology company developing novel therapies intended to restore skeletal muscle health. Its first-in-class platform develops small-molecule treatments that selectively target skeletal muscle for rare neuromuscular diseases and broader age-related conditions. The company builds on more than 15 years of muscle-physiology research, combining biological insight, proprietary enabling technologies, drug discovery capabilities, and in vivo pharmacology models.
Summary
It lists 11–50 employees. It has raised $168.3M in total across 3 rounds, most recently a $81.3M Series B round in Nov 2023. Investors include Jeito Capital, Inkef and Novo Holdings A/S.
Funding History
Nov 2023
Sign up to see all 3 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nmd-pharma"><img src="https://indexed.vc/api/badge/company/nmd-pharma" alt="NMD Pharma on Indexed.vc" width="260" height="76" /></a>